ZWZhengkun Wang

Zhengkun Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zhengkun Wang has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Erratum to: Clusterin confers gemcitabine resistance in pancreatic cancer

    by Qingfeng Chen, Zhengkun Wang, Kejun Zhang, Xiaoyi Liu, Weihong Cao, Lei Zhang, Shuhua Zhang, Bomin Yan, Yaoguang Wang, Chunping Xia


  • Open Access

    Clusterin confers gmcitabine resistance in pancreatic cancer

    by Qingfeng Chen, Zhengkun Wang, Kejun Zhang, Xiaoyi Liu, Weihong Cao, Lei Zhang, Shuhua Zhang, Bomin Yan, Yaoguang Wang, Chunping Xia

    Objective: To measure clusterin expression in pancreatic cancer tissues and cell lines and to evaluate whether clusterin confers resistance to gmcitabine in pancreatic cancer cells.Methods: Immunohistochemistry for clusterin was performed on 50 primary pancreatic cancer tissues and 25 matched backgrounds, and clusterin expression in 5 pancreatic cancer cell lines was quantified by Western blot and PT-PCR. The correlation between clusterin expression level and gmcitabine IC50 in pancreatic cancer cell lines was evaluated. The effect of an antisense oligonucleotide (ASO) against clusterin(OGX-011) on gmcitabine resistance was evaluated by MTT assays. Xenograft model was used to demonstrate tumor growth.Results: Pancreatic cancer tissues expressed significantly higher levels of clusterin than did normal pancreatic tissues (P< 0.01). Clusterin expression levels were correlated with gmcitabine resistance in pancreatic cancer cell lines, and OGX-011 significantly decreased BxPc-3 cells resistance to gmcitabine (P< 0.01).In vivosystemic administration of AS clusterin and gmcitabine significantly decreased the s.c. BxPC-3 tumor volume compared with mismatch control ODN plus gmcitabine.Conclusion: Our finding that clusterin expression was significantly higher in pancreatic cancer than in normal pancreatic tissues suggests that clusterin may confer gmcitabine resistance in pancreatic cancer cells.